Overview

Study of NU172 as Anticoagulation in Patients Undergoing Off-pump CABG Surgery

Status:
Unknown status
Trial end date:
2013-09-01
Target enrollment:
Participant gender:
Summary
This is a Phase 2, multicenter, open-label, single-arm, sequential cohort study to be conducted in up to 30 subjects. The study will evaluate subjects undergoing primary, elective, off-pump CABG surgery with median sternotomy.
Phase:
Phase 2
Details
Lead Sponsor:
ARCA Biopharma, Inc.